{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T21:11:38Z","timestamp":1716671498156},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/bf03350342","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T22:29:58Z","timestamp":1397168998000},"page":"784-788","source":"Crossref","is-referenced-by-count":2,"title":["Patients affected by vitiligo and autoimmune diseases do not show antibodies interfering with the activity of the melanocortin 1 receptor"],"prefix":"10.1007","volume":"33","author":[{"given":"P.","family":"Agretti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Sansone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Betterle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Coco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dimida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ferrarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pinchera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tonacchera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,11]]},"reference":[{"key":"BF03350342_CR1","first-page":"137","volume":"14","author":"RH Huggins","year":"2005","unstructured":"Huggins RH, Schwartz RA, Janniger CK. Vitiligo. Acta Dermatovenerol Alp Panonica Adriat 2005, 14: 137\u201345.","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"BF03350342_CR2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/archderm.1977.01640110035002","volume":"113","author":"C Macaron","year":"1977","unstructured":"Macaron C, Winter RJ, Traisman HS, Kahan BD, Lasser AE, Green OC. Vitiligo and juvenile diabetes mellitus. Arch Dermatol 1977, 113: 1515\u20137.","journal-title":"Arch Dermatol"},{"key":"BF03350342_CR3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.7326\/0003-4819-71-5-935","volume":"71","author":"Y Ochi","year":"1969","unstructured":"Ochi Y, DeGroot LJ. Vitiligo in Graves\u2019 disease. Ann Intern Med 1969, 71: 935\u201340.","journal-title":"Ann Intern Med"},{"key":"BF03350342_CR4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/003693308302800405","volume":"28","author":"BM Goudie","year":"1983","unstructured":"Goudie BM, Wilkieson C, Goodie RB. A family study of vitiligo patterns. Scott Med J 1983, 28: 338\u201342.","journal-title":"Scott Med J"},{"key":"BF03350342_CR5","first-page":"119","volume":"43","author":"PP Majumder","year":"1988","unstructured":"Majumder PP, Das SK, Li CC. A genetical model for vitiligo. Am J Hum Gen 1988, 43: 119\u201325.","journal-title":"Am J Hum Gen"},{"key":"BF03350342_CR6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2133.2001.04288.x","volume":"145","author":"M Zamani","year":"2001","unstructured":"Zamani M, Spaepen M, Sghar SS, et al. Linkage and association of HLA class II genes with vitiligo in a Dutch population. Br J Dermatol 2001, 145: 90\u20134.","journal-title":"Br J Dermatol"},{"key":"BF03350342_CR7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2340\/0001555574124128","volume":"74","author":"L Hegedus","year":"1994","unstructured":"Hegedus L, Heidenheim M, Gervil M, Hjalgrim H, Hoier-Madsen M. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol 1994, 74: 120\u20133.","journal-title":"Acta Derm Venereol"},{"key":"BF03350342_CR8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/08916939209035163","volume":"11","author":"R Lorini","year":"1992","unstructured":"Lorini R, Orecchia G, Martinetti M, Dugoujon JM, Cuccia M. Autoimmunity in vitiligo: relationship with HLA Gm and Km polymorphisms. Autoimmunity 1992, 11: 255\u201360.","journal-title":"Autoimmunity"},{"key":"BF03350342_CR9","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/archderm.1976.01630330082038","volume":"112","author":"C Betterle","year":"1976","unstructured":"Betterle C, Del Prete GF, Peserico A, et al. Antibodies in vitiligo. Arch Dermatol 1976, 112: 1328.","journal-title":"Arch Dermatol"},{"key":"BF03350342_CR10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000249466","volume":"171","author":"C Betterle","year":"1985","unstructured":"Betterle C, Caretto A, De Zio A, et al. Incidence and significance of organ-specific autoimmune disorders (clinical, latent or only autoantibodies) in patients with vitiligo. Dermatologica 1985, 171: 419\u201323.","journal-title":"Dermatologica"},{"key":"BF03350342_CR11","first-page":"1532","volume":"134","author":"MD Njoo","year":"1998","unstructured":"Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PM. Nonsurgical repigmentation therapies in vitiligo: meta-analysis of the literature. Arch Dermatol 1998, 134: 1532\u201340.","journal-title":"Arch Dermatol"},{"key":"BF03350342_CR12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","volume":"139","author":"V Lepe","year":"2003","unstructured":"Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 2003, 139: 581\u20135.","journal-title":"Arch Dermatol"},{"key":"BF03350342_CR13","first-page":"239","volume":"60","author":"RA Shwartz","year":"1997","unstructured":"Shwartz RA, Janniger CK. Vitiligo. Cutis 1997, 60: 239\u201344.","journal-title":"Cutis"},{"key":"BF03350342_CR14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0190-9622(98)70194-X","volume":"38","author":"SO Kovacs","year":"1998","unstructured":"Kovacs SO. Vitiligo. J Am Acad Dermatol 1998, 38: 647\u201366.","journal-title":"J Am Acad Dermatol"},{"key":"BF03350342_CR15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI0214643","volume":"109","author":"EH Kemp","year":"2002","unstructured":"Kemp EH, Waterman EA, Hawes BE, et al. The melanocortin receptor 1, a novel target of autoantibody responses in vitiligo. J Clin Invest 2002, 109: 923\u201330.","journal-title":"J Clin Invest"},{"key":"BF03350342_CR16","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/labinvest.3780138","volume":"80","author":"R Wijngaard van den","year":"2000","unstructured":"van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, Tigges B, Westerhof W, Das P. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest 2000, 80: 1299\u2013309.","journal-title":"Lab Invest"},{"key":"BF03350342_CR17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0738-081X(89)90063-1","volume":"7","author":"JC Bystryn","year":"1989","unstructured":"Bystryn JC. Serum antibodies in vitiligo patients. Clin Dermatol 1989, 7: 136\u201345.","journal-title":"Clin Dermatol"},{"key":"BF03350342_CR18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","volume":"16","author":"K Ongenae","year":"2003","unstructured":"Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 2003, 16: 90\u2013100.","journal-title":"Pigment Cell Res"},{"key":"BF03350342_CR19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/1523-1747.ep12555773","volume":"98","author":"J Cui","year":"1992","unstructured":"Cui J, Harning R, Henn M, Bystryn JC. Identification of pigment cell antigens defined by vitiligo antibodies. J Invest Dermatol 1992, 98: 162\u20135.","journal-title":"J Invest Dermatol"},{"key":"BF03350342_CR20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0749.1995.tb00774.x","volume":"8","author":"J Cui","year":"1995","unstructured":"Cui J, Arita Y, Bystryn JC. Characterization of vitiligo antigens. Pigment Cell Res 1995, 8: 53\u20139.","journal-title":"Pigment Cell Res"},{"key":"BF03350342_CR21","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1056\/NEJM197709222971204","volume":"12","author":"KC Hertz","year":"1977","unstructured":"Hertz KC, Gazze LA, Kirkpatrick CH, Katz SI. Autoimmune vitiligo: detection of antibodies to melanin-producing cells. N Engl J Med 1977, 12: 634\u20137.","journal-title":"N Engl J Med"},{"key":"BF03350342_CR22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0140-6736(84)90084-9","volume":"1","author":"C Betterle","year":"1984","unstructured":"Betterle C, Mirakian R, Doniach D, Bottazzo GF, Riley W, Maclaren N. Antibodies to melanocytes in vitiligo. Lancet 1984, 1: 159.","journal-title":"Lancet"},{"key":"BF03350342_CR23","first-page":"359","volume":"14","author":"E Baharav","year":"1996","unstructured":"Baharav E, Gur H, Fishman P, et al. Superantigens and experimental SLE induced by idiotypic dysregulation. Clin Exp Rheumatol 1996, 14: 359\u201366.","journal-title":"Clin Exp Rheumatol"},{"key":"BF03350342_CR24","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(94)91709-4","volume":"344","author":"YH Song","year":"1994","unstructured":"Song YH, Connor E, Li Y, Zorovich B, Balducci P, Maclaren N. The role of tyrosinase in autoimmune vitiligo. Lancet 1994, 344: 1049\u201352.","journal-title":"Lancet"},{"key":"BF03350342_CR25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/1523-1747.ep12276556","volume":"109","author":"EH Kemp","year":"1997","unstructured":"Kemp EH, Gawkrodger DJ, MacNeil S, Watson PF, Weetman AP. Detection of tyrosinase autoantibodies in vitiligo patients using 35S-labelled recombinanat human tyrosinase in a radioimmunoassay. J Invest Dermatol 1997, 109: 69\u201373.","journal-title":"J Invest Dermatol"},{"key":"BF03350342_CR26","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1046\/j.1365-2133.1998.02503.x","volume":"139","author":"EH Kemp","year":"1998","unstructured":"Kemp EH, Waterman EA, Gawkrodger DJ, Watson PF, Weetman AP. Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay. Br J Dermatol 1998, 139: 798\u2013805.","journal-title":"Br J Dermatol"},{"key":"BF03350342_CR27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.1997.4781381.x","volume":"109","author":"EH Kemp","year":"1997","unstructured":"Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP. Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin Exp Immunol 1997, 109: 495\u2013500.","journal-title":"Clin Exp Immunol"},{"key":"BF03350342_CR28","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","volume":"111","author":"T Okamoto","year":"1998","unstructured":"Okamoto T, Irie RF, Fujii S, et al. Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy. J Invest Dermatol 1998, 111: 1034\u20139.","journal-title":"J Invest Dermatol"},{"key":"BF03350342_CR29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2249.1998.00746.x","volume":"114","author":"EH Kemp","year":"1998","unstructured":"Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP. Autoantibodies to human melanocyte-specific protein Pmel17 in the sera of vitiligo patients: a sensitive and quantitative immunoassay (RIA). Clin Exp Immunol 1998, 114: 333\u20138.","journal-title":"Clin Exp Immunol"},{"key":"BF03350342_CR30","doi-asserted-by":"crossref","first-page":"35390","DOI":"10.1074\/jbc.M102391200","volume":"276","author":"H Hedstrand","year":"2001","unstructured":"Hedstrand H, Ekwall O, Olsson MJ, et al. The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I. J Biol Chem 2001, 276: 35390\u20135.","journal-title":"J Biol Chem"},{"key":"BF03350342_CR31","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/labinvest.3700438","volume":"86","author":"RV Gottumukkala","year":"2006","unstructured":"Gottumukkala RV, Gavalas NG, Akhtar S, et al. Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients. Lab Invest 2006, 86: 781\u20139.","journal-title":"Lab Invest"},{"key":"BF03350342_CR32","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF00372074","volume":"284","author":"PD Donatien","year":"1992","unstructured":"Donatien PD, Hunt G, Pieron C, Lunec J, Taieb A, Thody AJ. The expression of functional MSH receptors on cultured human melanocytes. Arch Dermatol Res 1992, 284: 424\u20136.","journal-title":"Arch Dermatol Res"},{"key":"BF03350342_CR33","first-page":"6352","volume":"49","author":"W Siegrist","year":"1989","unstructured":"Siegrist W, Solca F, Stutz S, et al. Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells. Cancer Res 1989, 49: 6352\u20138.","journal-title":"Cancer Res"},{"key":"BF03350342_CR34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1600-0749.2005.00278.x","volume":"18","author":"JC Garcia-Borron","year":"2005","unstructured":"Garcia-Borron JC, Sanchez-Laorden BL, Jimenez-Cervantes C. Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res 2005, 18: 393\u2013410.","journal-title":"Pigment Cell Res"},{"key":"BF03350342_CR35","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1034\/j.1600-0749.2003.00073.x","volume":"16","author":"JS M\u00e1s","year":"2003","unstructured":"M\u00e1s JS, Gerritsen I, Hahmann C, Jim\u00e9nez-Cervantes C, Garc\u00eda-Borr\u00f3n JC. Rate limiting factors in melanocortin 1 receptor signalling through the cAMP pathway. Pigment Cell Res 2003, 16: 540\u20137.","journal-title":"Pigment Cell Res"},{"key":"BF03350342_CR36","first-page":"499","volume":"76","author":"P Vitti","year":"1993","unstructured":"Vitti P, Elisei R, Tonacchera M, et al. Detection of thyroid stimulating antibody using Chinese hamster ovary cells transfected with the cloned human thyrotropin receptor. J Clin Endocrinol Metabol 1993, 76: 499\u2013503.","journal-title":"J Clin Endocrinol Metabol"},{"key":"BF03350342_CR37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","volume":"16","author":"A Alkhateeb","year":"2003","unstructured":"Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo associated autoimmune diseases in Caucasian probands and their family. Pigment Cell Res 2003, 16: 208\u201314.","journal-title":"Pigment Cell Res"},{"key":"BF03350342_CR38","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1523-1747.2003.12494.x","volume":"121","author":"RV Gottumukkala","year":"2003","unstructured":"Gottumukkala RV, Waterman EA, Herd LM, et al. Autoantibodies in vitiligo patients recognize multiple domains of the melaninconcentrating hormone receptor. J Invest Dermatol 2003, 121: 765\u201370.","journal-title":"J Invest Dermatol"},{"key":"BF03350342_CR39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000081479","volume":"210","author":"P Iacovelli","year":"2005","unstructured":"Iacovelli P, Sinagra JL, Vidolin AP, et al. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology 2005, 210: 26\u201330.","journal-title":"Dermatology"},{"key":"BF03350342_CR40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/08916930108994127","volume":"34","author":"EH Kemp","year":"2001","unstructured":"Kemp EH, Waterman EA, Weetman AP. Autoimmune aspects of vitiligo. Autoimmunity 2001, 34: 65\u201377.","journal-title":"Autoimmunity"},{"key":"BF03350342_CR41","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/1097-0142(19931015)72:8<2365::AID-CNCR2820720812>3.0.CO;2-G","volume":"72","author":"P Fishman","year":"1993","unstructured":"Fishman P, Azizi E, Shoenfeld Y, et al. Vitiligo autoantibodies are effective against melanoma. Cancer 1993, 72: 2365\u20139.","journal-title":"Cancer"},{"key":"BF03350342_CR42","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1084\/jem.158.1.246","volume":"158","author":"GK Naughton","year":"1983","unstructured":"Naughton GK, Eisinger M, Bystryn JC. Antibodies to normal human melanocyte in vitiligo. J Exp Med 1983, 158: 246\u201351.","journal-title":"J Exp Med"},{"key":"BF03350342_CR43","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12324456","volume":"105","author":"A Gilhar","year":"1995","unstructured":"Gilhar A, Zelickson B, Ulman Y, Etzioni A. In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo. J Invest Dermatol 1995, 105: 683\u20136.","journal-title":"J Invest Dermatol"},{"key":"BF03350342_CR44","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0190-9622(86)70260-0","volume":"15","author":"GK Naughton","year":"1986","unstructured":"Naughton GK, Reggiardo D, Bystryn JC. Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol 1986, 15: 978\u201381.","journal-title":"J Am Acad Dermatol"},{"key":"BF03350342_CR45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-0749.1995.tb00775.x","volume":"8","author":"J Cui","year":"1995","unstructured":"Cui J, Chen D, Misfeldt ML, Swinfard RW, Bystryn JC. Antimelanoma antibodies in swine with spontaneously regressing melanoma. Pigment Cell Res 1995, 8: 60\u201363.","journal-title":"Pigment Cell Res"},{"key":"BF03350342_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0749.1994.tb00013.x","volume":"7","author":"MB Abdel Naser","year":"1994","unstructured":"Abdel Naser MB, Kruger-Krasagakes S, Krasagakis K, Gollnick H, Orfanos CE. Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo. Pigment Cell Res 1994, 7: 1\u20138.","journal-title":"Pigment Cell Res"},{"key":"BF03350342_CR47","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/clinchem\/30.7.1137","volume":"30","author":"M Blecher","year":"1984","unstructured":"Blecher M. Receptors, antibodies, and disease. Clin Chem 1984, 30: 1137\u201356.","journal-title":"Clin Chem"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03350342.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03350342\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03350342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T20:50:51Z","timestamp":1716670251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03350342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["BF03350342"],"URL":"https:\/\/doi.org\/10.1007\/bf03350342","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}